United-Guardian (UG) 10-K 24 Mar 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 01, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'UNITED GUARDIAN INC	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Common Stock, Shares Outstanding	'	4,596,439	'
Entity Public Float	'	'	$63,699,836
Amendment Flag	'false	'	'
Entity Central Index Key	'0000101295	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

Statements_of_Income

Statements of Income (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Net sales	$15,416,893	$13,825,764
Costs and expenses:	'	'
Cost of sales	5,610,813	5,218,959
Operating expenses	2,504,526	2,508,334
Total costs and expenses	8,115,339	7,727,293
Income from operations	7,301,554	6,098,471
Other income (expense):	'	'
Investment income	259,747	325,017
(Loss) on sale of assets	'	-14,861
Income from damage settlement	1,070,561	518,050
Total other income, net	1,330,308	828,206
Income from operations before income taxes	8,631,862	6,926,677
Provision for income taxes	2,728,553	2,095,897
Net income	$5,903,309	$4,830,780
Earnings per common share (basic and diluted) (in Dollars per share)	$1.28	$1.05
Weighted average shares (basic and diluted) (in Shares)	4,596,439	4,596,439

Statements_of_Comprehensive_In

Statements of Comprehensive Income (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Net income	$5,903,309	$4,830,780
Other comprehensive (loss) income:	'	'
Unrealized (loss) gain on marketable securities	-71,711	220,946
Income tax benefit (expense)	24,855	-76,579
Other comprehensive (loss) income, net of tax	-46,856	144,367
Comprehensive income	$5,856,453	$4,975,147

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets:	'	'
Cash and cash equivalents	$1,634,262	$1,748,382
Marketable securities	8,863,205	7,743,946
Accounts receivable, net of allowance for doubtful accounts of $18,000 in 2013 and $29,000 in 2012	1,790,747	1,017,627
Receivable in connection with damage settlement	48,805	518,050
Inventories (net)	1,610,747	1,242,750
Prepaid expenses and other current assets	130,001	132,458
Prepaid income taxes	'	3,602
Deferred income taxes	229,451	216,588
Total current assets	14,307,218	12,623,403
Property, plant, and equipment:	'	'
Land	69,000	69,000
Factory equipment and fixtures	4,090,968	3,842,927
Building and improvements	2,766,319	2,725,993
Waste disposal plant	133,532	133,532
Total property, plant and equipment	7,059,819	6,771,452
Less accumulated depreciation	5,725,318	5,535,589
Net property, plant, and equipment	1,334,501	1,235,863
Other asset:	9,147	'
Total assets	15,650,866	13,859,266
Current liabilities:	'	'
Accounts payable	385,699	151,385
Accrued expenses	728,015	676,123
Income taxes payable	131,638	'
Total current liabilities	1,245,352	827,508
Deferred income taxes	169,587	193,740
Common stock, $.10 par value; 10,000,000 shares authorized; 4,596,439 shares issued and outstanding at December 31, 2013 and 2012, respectively	459,644	459,644
Accumulated other comprehensive income	132,123	178,979
Retained earnings	13,644,160	12,199,395
Total stockholders’ equity	14,235,927	12,838,018
Total liabilities and stockholders’ equity	$15,650,866	$13,859,266

Balance_Sheets_Parentheticals

Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accounts receivable, allowance (in Dollars)	$18,000	$29,000
Common stock, par value (in Dollars per share)	$0.10	$0.10
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	4,596,439	4,596,439
Common stock, shares outstanding	4,596,439	4,596,439

Statement_Of_Stockholders_Equi

Statement Of Stockholders' Equity (USD $)	Common Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2011	$459,644	$34,612	$13,619,773	$14,114,029
Balance (Shares) (in Shares) at Dec. 31, 2011	4,596,439	'	'	'
Change in unrealized gains on marketable securities, net of deferred income tax	'	144,367	'	144,367
Net income	'	'	4,830,780	4,830,780
Dividends declared	'	'	-6,251,158	-6,251,158
Balance at Dec. 31, 2012	459,644	178,979	12,199,395	12,838,018
Balance (Shares) (in Shares) at Dec. 31, 2012	4,596,439	'	'	'
Change in unrealized gains on marketable securities, net of deferred income tax	'	-46,856	'	-46,856
Net income	'	'	5,903,309	5,903,309
Dividends declared	'	'	-4,458,544	-4,458,544
Balance at Dec. 31, 2013	$459,644	$132,123	$13,644,160	$14,235,927
Balance (Shares) (in Shares) at Dec. 31, 2013	4,596,439	'	'	'

Statement_Of_Stockholders_Equi1

Statement Of Stockholders' Equity (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Change in unrealized gains on marketable securities, deferred income tax benefit	$24,855	($76,579)

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net income	$5,903,309	$4,830,780
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	189,729	254,441
Net loss on sale of assets	'	14,861
Realized (gain) loss on sales of marketable securities	-18,675	22,931
(Decrease) increase in allowance for bad debts	-11,089	11,054
Deferred income taxes	-12,161	59,541
(Decrease) increase in cash resulting from changes in operating assets and liabilities:	'	'
Accounts receivable	-762,031	624,758
Receivable from damage settlement	469,245	-518,050
Inventories	-367,997	224,684
Prepaid expenses and other current and non-current assets	-6,690	30,576
Prepaid income taxes	3,602	75,011
Accounts payable	234,314	-249,004
Accrued expenses and taxes payable	183,530	-836
Net cash provided by operating activities	5,805,086	5,380,747
Cash flows from investing activities:	'	'
Acquisitions of plant and equipment	-288,367	-252,356
Proceeds from the sale of assets	'	30,350
Purchases of marketable securities	-5,311,313	-4,266,419
Proceeds from sales of marketable securities	4,139,018	6,016,244
Net cash (used in) provided by investing activities	-1,460,662	1,527,819
Cash flows from financing activities:	'	'
Dividends paid	-4,458,544	-6,251,158
Net cash used in financing activities	-4,458,544	-6,251,158
Net (decrease) increase in cash and cash equivalents	-114,120	657,408
Cash and cash equivalents, beginning of year	1,748,382	1,090,974
Cash and cash equivalents, end of year	$1,634,262	$1,748,382

Note_A_Nature_of_Business_and_

Note A - Nature of Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	'
	NOTE A - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Nature of Business
	United-Guardian, Inc. (the "Company") is a Delaware corporation that, through its Guardian Laboratories Division, conducts research, product development, manufacturing and marketing of cosmetic ingredients and other personal care products, pharmaceuticals, medical and health care products, and proprietary specialty industrial products. Two major product lines, LUBRAJEL™ and RENACIDIN™ IRRIGATION (“RENACIDIN”) together accounted for 94.4% and 94.1% of revenue for the years ended December 31, 2013 and December 31, 2012, respectively. LUBRAJEL accounted for 91.4% and 86.5% of revenue for the years ended December 31, 2013 and December 31, 2012, respectively, and RENACIDIN accounted for 2.9% and 7.6% of revenue for the years ended December 31, 2013 and December 31, 2012, respectively.
	Accounts Receivable and Reserves
	The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected. The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns.  In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends. From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.
	Revenue Recognition
	The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  All products are shipped Free On Board (“FOB”) Hauppauge, New York, the location of the Company’s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company’s plant.  Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured.  All sales of the Company’s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.
	Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.
	Cash and Cash Equivalents
	For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception.  The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.
	Dividends
	On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.
	On May 16, 2012, the Company’s Board of Directors declared a semi-annual cash dividend of $0.42 per share, which was paid on June 18, 2012 to all stockholders of record as of June 4, 2012. On December 4, 2012, the Company’s Board of Directors declared a semi-annual cash dividend of $0.44 per share and a special dividend of $0.50 per share, which were paid on December 21, 2012 to all stockholders of record as of December 14, 2012. Total dividends declared and paid in 2012 were $6,251,158.
	Supplemental Disclosures of Non-cash Investing and Financing Activities
	Cash payments for income taxes were $2,605,474 and $2,024,245 for the years ended December 31, 2013 and 2012, respectively.
	Marketable Securities
	Marketable securities include investments in equity and fixed income mutual funds, government securities and corporate bonds, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices.  The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.
	Inventories
	Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Inventory costs include material, labor and factory overhead.
	Property, Plant and Equipment
	Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.
	Estimated useful lives are as follows:
	Factory equipment and fixtures (years)	5	-	7
	Building (years)		40
	Building improvements		Lesser of useful
			life or 20 years
	Waste disposal system (years)		7
	Impairment of Long-Lived Assets
	Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  No impairments were necessary at December 31, 2013 and 2012.
	Other Asset
	Other asset at December 31, 2013 consisted of costs incurred relating to the new production process for RENACIDIN.
	Fair Value of Financial Instruments
	Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms.
	Concentration of Credit Risk
	Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all.  It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.  As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.
	For the year ended December 31, 2013, two customers, both of them distributors and marketing partners of the Company, accounted for approximately 69% of the Company’s revenues during the year, and 72% of its outstanding accounts receivable at year end.  For the year ended December 31, 2012, these same two customers accounted for a total of 62% of the Company’s revenues during the year, and 52% of its outstanding accounts receivable at year end.
	Vendor Concentration
	The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that accounted for approximately 67% and 77% of the raw material purchases by the Company in 2013 and 2012, respectively.
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
	Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2013 and 2012, the Company did not have any unrecognized income tax benefits.  It is the Company’s policy to recognize interest and penalties related to taxes as interest expense as incurred.  During the years ended December 31, 2013 and 2012 the Company did not record any interest or penalties. The Company’s tax returns are subject to examination by the United States Internal Revenue Service for years 2010 through 2012. In March 2014 the Department of Taxation of the State of New York (“DOT”) commenced an examination of the Company’s income tax returns for years 2010 through 2012. The Company has already provided the DOT with some preliminary information that it requested.
	Research and Development
	The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $717,000 and $693,000 for the years ended December 31, 2013 and 2012, respectively.
	Shipping and Handling Costs
	Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $45,000 and $65,000 for the years ended December 31, 2013 and 2012, respectively.
	Advertising Costs
	Advertising costs are expensed as incurred. During 2013 and 2012 the Company incurred $16,000 and $24,000, respectively, in advertising costs.
	Stock-Based Compensation
	In 2004, the Company approved a stock option plan ("2004 Stock Option Plan"). All share-based payments to employees, including grants of employee stock options, are recognized as compensation expense over the requisite service period (generally the vesting period) in the financial statements based on their fair values on grant date. For options with graded vesting, the Company fair values the stock option grants and recognizes compensation expense as if each vesting portion of the award was a separate award. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount of expense recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity rather than as an operating activity.
	Earnings Per Share Information
	Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.
	Use of Estimates
	In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.
	New Accounting Standards
	In February 2013, FASB issued ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” This update requires the Company to report amounts being reclassified out of accumulated other comprehensive income by component. It also requires the Company to report either on the face of the financial statements or in the notes any significant amounts reclassified out of accumulated other comprehensive income, by the respective line items of net income, but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.  For those amounts not required to be reclassified directly to net income in their entirety, the Company is required to cross-reference other disclosures that provide further details about the amounts.  The amendments are effective for reporting periods beginning after December 15, 2012.  The Company adopted this amendment effective January 1, 2013.  The adoption of this amendment did not have a material impact on the Company’s results of operations.
	In December of 2013, FASB issued ASU 2013-12, “Definition of a Public Business Entity.” This amendment clarifies the definition of what is a public entity as compared to a private entity to minimize the inconsistency and complexity of having multiple definitions for applying U.S. generally accepted accounting principles.  It does not affect existing requirements and there is no effective date for adoption.  This amendment does not affect the Company’s results of operations.
	In December of 2013, FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.  This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company’s results of operation and at the present time it does not apply to the Company.

Note_B_Marketable_Securities

Note B - Marketable Securities	12 Months Ended
	Dec. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	'
	NOTE B - MARKETABLE SECURITIES
	The fair values of the Company’s marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value as follows:
	•	Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	•	Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	•	Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.
	The following available-for-sale securities, which comprise all of the Company's marketable securities, are re-measured to fair value on a recurring basis and are valued using Level 1 inputs using quoted prices (unadjusted) for identical assets in active markets:
			Cost		Fair Value		Unrealized
	31-Dec-13						Gain/(Loss)
	Available for sale:
	Corporate bonds (matures within 1 year)		$	203,920	$	200,053	$	(3,867	)
	Fixed income mutual funds			7,325,930		7,425,687		99,757
	Equity and other mutual funds			1,131,147		1,237,465		106,318
			$	8,660,997	$	8,863,205	$	202,208
	31-Dec-12
	Available for sale:
	Corporate bonds (maturities of 1-5 years)		$	203,920	$	203,357	$	(563	)
	Fixed income mutual funds			6,991,181		7,242,998		251,817
	Equity and other mutual funds			274,926		297,591		22,665
			$	7,470,027	$	7,743,946	$	273,919
	Proceeds from the sale and redemption of marketable securities amounted to $4,139,018 and $6,016,244 for the years ended December 31, 2013 and 2012, respectively. Gains of $18,675 and losses of $22,931 were realized for the years ended December 31, 2013 and 2012, respectively.
	Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds and money market funds, and dividend income from bond funds and mutual funds.

Note_C_Inventories

Note C - Inventories	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	NOTE C – INVENTORIES
	Inventories consist of the following:
		December 31,
		2013		2012
	Raw materials and work-in-process	$	488,757	$	481,544
	Finished products		1,121,990		761,206
		$	1,610,747	$	1,242,750
	Finished product inventories at December 31, 2013 and 2012 are stated net of a reserve of $20,000 for slow moving and obsolete items.

Note_D_Income_Taxes

Note D - Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE D – INCOME TAXES
	The provision for income taxes consists of the following:
		Years ended December 31,
	Current	2013			2012
	Federal	$	2,721,068		$	2,015,345
	State		19,646			21,011
			2,740,714			2,036,356
	Deferred
	Federal		(11,810	)		57,823
	State		(351	)		1,718
			(12,161	)		59,541
	Total provision for income taxes	$	2,728,553		$	2,095,897
	The following is a reconciliation of the Company’s effective income tax rate to the Federal statutory rate (dollar amounts have been rounded to the nearest thousand):
		Years ended December 31,
		2013						2012
		($)			Tax rate			($)			Tax rate
	Income taxes at statutory federal income tax rate of 34%	$	2,935,000			34	%	$	2,355,000			34	%
	State income taxes, net of Federal benefit		13,000			0.2			14,000			0.2
	Domestic Production Activities tax benefit		(180,000	)		(2.1	)		(167,000	)		(2.4	)
	Nondeductible expenses		1,000			-			1,000			-
	Prior year over-accrual		(19,000	)		(0.2	)		(24,000	)		(0.4	)
	R&D credits		(20,000	)		(0.2	)		(83,000	)		(12.1	)
	Other, misc		(1,000	)					1,000
	Tax exempt income		-			-			(1,000	)		-
	Actual income tax expense	$	2,729,000			31.7	%	$	2,096,000			30	%
	During 2013 and 2012, the Company realized the tax benefits of the Domestic Production Activities deduction, which amounted to approximately 9% of net income from domestic production activities in each year.
	The tax effects of temporary differences which comprise the deferred tax assets and liabilities are as follows:
		Years ended December 31,
		2013			2012
	Deferred tax assets
	Current
	Accounts receivable	$	6,089		$	9,933
	Inventories		16,862			14,348
	Accrued expenses		206,500			192,307
			229,451			216,588
	Deferred tax liabilities
	Non-current
	Depreciation		(99,502	)		(98,800	)
	Unrealized gain on marketable securities		(70,085	)		(94,940	)
			(169,587	)		(193,740	)
	Net deferred tax asset	$	59,864		$	22,848

Note_E_Benefit_Plans

Note E - Benefit Plans	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	NOTE E - BENEFIT PLANS
	Defined Contribution Plan
	The Company sponsors a 401(k) defined contribution plan ("DC Plan") that provides for a dollar-for-dollar employer matching contribution of the first 4% of each employee's pay. Employees become fully vested in employer matching contributions after one year of employment. Company 401(k) matching contributions were approximately $101,000 and $96,000 for each of the years ended December 31, 2013 and 2012.  In 2013 and 2012 employees were able to defer up to $17,500 and $17,000, respectively (plus $5,500 for employees over the age of 50) of their yearly pay as a pre-tax investment in the 401(k)plan, in accordance with limits set by the IRS. (Those limits of $17,500 (plus an additional $5,500 for employees over the age of 50) will be the same in 2014).
	The Company also makes discretionary contributions to each employee's account based on a "pay-to-pay" safe-harbor formula that qualifies the 401(k) plan under current IRS regulations. In December 2013 and 2012 the Company’s Board of Directors authorized discretionary contributions in the amount of $175,000 per year, to be allocated among all eligible employees, for the 2013 and 2012 plan years. The 2013 contribution was paid in 2013, and the 2012 contribution was paid in 2012. Employees become vested in the discretionary contributions as follows: 20% after two years of employment, and 20% for each year of employment thereafter until the employee becomes fully vested after six years of employment.
	Stock Option Plans
	At its meeting on March 19, 2004 the Board of Directors of the Company approved the adoption of the 2004 Stock Option Plan. The plan authorizes the granting of options for up to 500,000 shares, and covers both employees and directors. The adoption and implementation of the plan was ratified by the shareholders of the Company at the Company's annual meeting of shareholders on May 19, 2004. As of December 31, 2013 and 2012, the Company had no share-based awards outstanding and exercisable and did not grant any options for these years.

Note_F_Geographic_and_Other_In

Note F - Geographic and Other Information	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	NOTE  F -  GEOGRAPHIC and OTHER INFORMATION
	Through its Guardian Laboratories division the Company manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical and health care products, and specialty industrial products.  It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s R&D department not only develops new products but also modifies and refines existing products, with the goal of expanding the potential markets for the Company's products. Many of the cosmetic ingredient products manufactured by Guardian, particularly its LUBRAJEL line of water-based moisturizing and lubricating gels, are currently used by many of the major multinational personal care products companies.
	The Company operates in one business segment. The Company’s products are separated into four distinct product categories: pharmaceuticals, personal care products (including cosmetic ingredients), medical products, and industrial products. Each product category is marketed differently. The cosmetic ingredient/personal care products are marketed through a global network of marketing partners and distributors.  These marketing partners purchase product outright from the Company and market and re-sell those products to the end users.  The Company does not make any sales on consignment.
	No prior regulatory approval was needed by the Company to sell any products other than its pharmaceutical products.  The end users of its products may or may not need regulatory approvals, depending on the intended claims and uses of those products.
	The pharmaceutical products are two urological products that are sold to end users primarily through distribution agreements with the major drug wholesalers. For these products, the Company does the marketing, and the drug wholesalers supply the product to the end users, such as hospitals and pharmacies. These products are drug products that required the Company to obtain regulatory approval before marketing.
	The medical products are not pharmaceutical products. They consist primarily of medical lubricants, which are marketed by the Company directly to manufacturers that incorporate them into urologic catheters and other medical devices and products that they sell. These products are distinguished from the pharmaceutical products in that, unlike the pharmaceutical products, the Company is not required to obtain regulatory approval prior to marketing these products. Approvals are the responsibility of the company that markets the medical device.  However, the Company is responsible for manufacturing these products in accordance with current Good Manufacturing Practices for medical devices.
	The industrial products are also marketed by the Company directly to manufacturers, and generally do not require that the Company obtain regulatory approval. However, the manufacturers of the finished products may have to obtain such regulatory approvals before marketing these products.
	The geographic information set forth in table "(b)" below is partially based on sales information provided to the Company by Customer A (shown in table "(c)" below), which exclusively markets the Company's cosmetic ingredients in Canada and China, and also sells some of the Company's products into France on a non-exclusive basis along with Customer B.
	(a)	Net Sales
			Years ended December 31,
			2013			2012
	Personal Care		$	11,459,482		$	9,438,345
	Medical			3,028,659			2,904,327
	Pharmaceutical			916,927			1,524,581
	Industrial and other			164,014			153,498
				15,569,082			14,020,751
	Less: Discounts and allowances			(152,189	)		(194,987	)
			$	15,416,893		$	13,825,764
	(b)	Geographic Information
			Years ended December 31,
			2013						2012
			Revenues			Long-Lived			Revenues		Long-Lived
						Assets					Assets
	United States		$	4,580,429		$	1,334,501		$	4,648,472	$	1,235,863
	Canada			3,390,619			-			2,860,154		-
	China			3,519,450			-			2,462,967		-
	France			856,285			-			903,137		-
	Other countries			3,070,110			-			2,951,034		-
			$	15,416,893		$	1,334,501		$	13,825,764	$	1,235,863
	(c)	Sales to Major Customers
			Years ended December 31,
			2013			2012
	Customer A		$	9,712,382		$	7,664,805
	Customer B			856,285			837,220
	All other customers			4,848,226			5,323,739
			$	15,416,893		$	13,825,764

Note_G_Comprehensive_Income

Note G - Comprehensive Income	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Comprehensive Income (Loss) Note [Text Block]	'
	NOTE G – COMPREHENSIVE INCOME
	Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.
	Changes in Accumulated Other	31-Dec-13			31-Dec-12
	Comprehensive Income
	Beginning balance - net of tax	$	178,979		$	34,612
	Unrealized (loss)/gain on marketable securities before reclassifications - net of tax		(65,531	)		167,298
	Realized gain/(loss) on sale of securities reclassified from accumulated other comprehensive income		18,675			(22,931	)
	Ending balance - net of tax	$	132,123		$	178,979

Note_H_Income_From_Damage_Sett

Note H - Income From Damage Settlement	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Interest and Other Income [Text Block]	'
	NOTE H - INCOME FROM DAMAGE SETTLEMENT
	In May 2012 the Company’s supplier of RENACIDIN curtailed production due to manufacturing issues. As a result of that curtailment, the Company and its supplier entered into a settlement agreement whereby the supplier agreed to pay the Company $518,050 for profit the Company lost during 2012 as a result of the curtailment, and an additional $97,610 per month beginning January 1, 2013 for each month that the curtailment continued. It also agreed to pay an additional $48,805 for the first two months after shipments resumed, and another $24,402 for the third month after production resumed, as “ramp-up” payments.  The payments were to continue until either the supply contract ended in January 2014 or product delivery resumed, whichever occurred first. Because deliveries resumed at the end of October of 2013, the obligation to pay $97,610 per month ceased as of that time, and the supplier’s remaining obligation was to pay the ramp-up payments for the next three months thereafter. The total amount of income that the Company earned in connection with the damage settlement totaled $1,070,561 in 2013, and $518,050 in 2012. In connection with those earnings the Company was due $48,805 and $518,050 at December 31, 2013 and 2012, respectively.

Note_I_Accrued_Expenses

Note I - Accrued Expenses	12 Months Ended
	Dec. 31, 2013
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Other Liabilities Disclosure [Text Block]	'
	NOTE I - ACCRUED EXPENSES
	Accrued expenses at December 31, 2013 and 2012 consist of:
		2013		2012
	Bonuses	$	250,000	$	229,000
	Distribution fees		196,558		196,617
	Payroll and related expenses		104,394		72,306
	Annual report expenses		66,000		66,000
	Audit fee		73,269		68,467
	Other		37,794		43,733
		$	728,015	$	676,123

Note_J_Related_Party_Transacti

Note J - Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	NOTE J - RELATED PARTY TRANSACTIONS
	During each of the years ended December 31, 2013 and 2012 the Company paid to Bonamassa, Maietta, and Cartelli, LLP, $14,000, and $13,000, respectively, for accounting and tax services. Lawrence Maietta, a partner in Bonamassa, Maietta, and Cartelli, LLP, is a director of the Company.
	During the fourth quarter of 2012 the President of the Company, Kenneth H. Globus, was reimbursed $24,408 for the value of the trade-in of a personal vehicle that was used to purchase a Company vehicle. For the year ended December 31, 2013 there were no such transactions.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Loans and Leases Receivable, Allowance for Loan Losses Policy [Policy Text Block]	'
	Accounts Receivable and Reserves
	The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected. The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns.  In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends. From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  All products are shipped Free On Board (“FOB”) Hauppauge, New York, the location of the Company’s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company’s plant.  Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured.  All sales of the Company’s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.
	Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash and Cash Equivalents
	For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception.  The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.
Stockholders' Equity, Policy [Policy Text Block]	'
	Dividends
	On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.
	On May 16, 2012, the Company’s Board of Directors declared a semi-annual cash dividend of $0.42 per share, which was paid on June 18, 2012 to all stockholders of record as of June 4, 2012. On December 4, 2012, the Company’s Board of Directors declared a semi-annual cash dividend of $0.44 per share and a special dividend of $0.50 per share, which were paid on December 21, 2012 to all stockholders of record as of December 14, 2012. Total dividends declared and paid in 2012 were $6,251,158.
Supplemental Disclosures of Non-Cash Investing and Financing Activities [Policy Text Block]	'
	Supplemental Disclosures of Non-cash Investing and Financing Activities
	Cash payments for income taxes were $2,605,474 and $2,024,245 for the years ended December 31, 2013 and 2012, respectively.
Marketable Securities, Policy [Policy Text Block]	'
	Marketable Securities
	Marketable securities include investments in equity and fixed income mutual funds, government securities and corporate bonds, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices.  The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.
Inventory, Policy [Policy Text Block]	'
	Inventories
	Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Inventory costs include material, labor and factory overhead.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property, Plant and Equipment
	Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.
	Estimated useful lives are as follows:
	Factory equipment and fixtures (years)	5	-	7
	Building (years)		40
	Building improvements		Lesser of useful
			life or 20 years
	Waste disposal system (years)		7
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	'
	Impairment of Long-Lived Assets
	Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  No impairments were necessary at December 31, 2013 and 2012.
Other Assets [Policy Text Block]	'
	Other Asset
	Other asset at December 31, 2013 consisted of costs incurred relating to the new production process for RENACIDIN.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentration of Credit Risk
	Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all.  It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.  As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.
	For the year ended December 31, 2013, two customers, both of them distributors and marketing partners of the Company, accounted for approximately 69% of the Company’s revenues during the year, and 72% of its outstanding accounts receivable at year end.  For the year ended December 31, 2012, these same two customers accounted for a total of 62% of the Company’s revenues during the year, and 52% of its outstanding accounts receivable at year end.
Vendor Concentration [Policy Text Block]	'
	Vendor Concentration
	The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that accounted for approximately 67% and 77% of the raw material purchases by the Company in 2013 and 2012, respectively.
Income Tax, Policy [Policy Text Block]	'
	Income Taxes
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
	Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2013 and 2012, the Company did not have any unrecognized income tax benefits.  It is the Company’s policy to recognize interest and penalties related to taxes as interest expense as incurred.  During the years ended December 31, 2013 and 2012 the Company did not record any interest or penalties. The Company’s tax returns are subject to examination by the United States Internal Revenue Service for years 2010 through 2012. In March 2014 the Department of Taxation of the State of New York (“DOT”) commenced an examination of the Company’s income tax returns for years 2010 through 2012. The Company has already provided the DOT with some preliminary information that it requested.
Research, Development, and Computer Software, Policy [Policy Text Block]	'
	Research and Development
	The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $717,000 and $693,000 for the years ended December 31, 2013 and 2012, respectively.
Shipping and Handling Cost, Policy [Policy Text Block]	'
	Shipping and Handling Costs
	Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $45,000 and $65,000 for the years ended December 31, 2013 and 2012, respectively.
Advertising Costs, Policy [Policy Text Block]	'
	Advertising Costs
	Advertising costs are expensed as incurred. During 2013 and 2012 the Company incurred $16,000 and $24,000, respectively, in advertising costs.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	In 2004, the Company approved a stock option plan ("2004 Stock Option Plan"). All share-based payments to employees, including grants of employee stock options, are recognized as compensation expense over the requisite service period (generally the vesting period) in the financial statements based on their fair values on grant date. For options with graded vesting, the Company fair values the stock option grants and recognizes compensation expense as if each vesting portion of the award was a separate award. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount of expense recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity rather than as an operating activity.
Earnings Per Share, Policy [Policy Text Block]	'
	Earnings Per Share Information
	Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	New Accounting Standards
	In February 2013, FASB issued ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” This update requires the Company to report amounts being reclassified out of accumulated other comprehensive income by component. It also requires the Company to report either on the face of the financial statements or in the notes any significant amounts reclassified out of accumulated other comprehensive income, by the respective line items of net income, but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period.  For those amounts not required to be reclassified directly to net income in their entirety, the Company is required to cross-reference other disclosures that provide further details about the amounts.  The amendments are effective for reporting periods beginning after December 15, 2012.  The Company adopted this amendment effective January 1, 2013.  The adoption of this amendment did not have a material impact on the Company’s results of operations.
	In December of 2013, FASB issued ASU 2013-12, “Definition of a Public Business Entity.” This amendment clarifies the definition of what is a public entity as compared to a private entity to minimize the inconsistency and complexity of having multiple definitions for applying U.S. generally accepted accounting principles.  It does not affect existing requirements and there is no effective date for adoption.  This amendment does not affect the Company’s results of operations.
	In December of 2013, FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.  This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company’s results of operation and at the present time it does not apply to the Company.

Note_B_Marketable_Securities_T

Note B - Marketable Securities (Tables)	12 Months Ended
	Dec. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	'
		Cost		Fair Value		Unrealized
	31-Dec-13					Gain/(Loss)
	Available for sale:
	Corporate bonds (matures within 1 year)	$	203,920	$	200,053	$	(3,867	)
	Fixed income mutual funds		7,325,930		7,425,687		99,757
	Equity and other mutual funds		1,131,147		1,237,465		106,318
		$	8,660,997	$	8,863,205	$	202,208
	31-Dec-12
	Available for sale:
	Corporate bonds (maturities of 1-5 years)	$	203,920	$	203,357	$	(563	)
	Fixed income mutual funds		6,991,181		7,242,998		251,817
	Equity and other mutual funds		274,926		297,591		22,665
		$	7,470,027	$	7,743,946	$	273,919

Note_C_Inventories_Tables

Note C - Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		December 31,
		2013		2012
	Raw materials and work-in-process	$	488,757	$	481,544
	Finished products		1,121,990		761,206
		$	1,610,747	$	1,242,750

Note_D_Income_Taxes_Tables

Note D - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
		Years ended December 31,
	Current	2013			2012
	Federal	$	2,721,068		$	2,015,345
	State		19,646			21,011
			2,740,714			2,036,356
	Deferred
	Federal		(11,810	)		57,823
	State		(351	)		1,718
			(12,161	)		59,541
	Total provision for income taxes	$	2,728,553		$	2,095,897
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
		Years ended December 31,
		2013						2012
		($)			Tax rate			($)			Tax rate
	Income taxes at statutory federal income tax rate of 34%	$	2,935,000			34	%	$	2,355,000			34	%
	State income taxes, net of Federal benefit		13,000			0.2			14,000			0.2
	Domestic Production Activities tax benefit		(180,000	)		(2.1	)		(167,000	)		(2.4	)
	Nondeductible expenses		1,000			-			1,000			-
	Prior year over-accrual		(19,000	)		(0.2	)		(24,000	)		(0.4	)
	R&D credits		(20,000	)		(0.2	)		(83,000	)		(12.1	)
	Other, misc		(1,000	)					1,000
	Tax exempt income		-			-			(1,000	)		-
	Actual income tax expense	$	2,729,000			31.7	%	$	2,096,000			30	%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		Years ended December 31,
		2013			2012
	Deferred tax assets
	Current
	Accounts receivable	$	6,089		$	9,933
	Inventories		16,862			14,348
	Accrued expenses		206,500			192,307
			229,451			216,588
	Deferred tax liabilities
	Non-current
	Depreciation		(99,502	)		(98,800	)
	Unrealized gain on marketable securities		(70,085	)		(94,940	)
			(169,587	)		(193,740	)
	Net deferred tax asset	$	59,864		$	22,848

Note_F_Geographic_and_Other_In1

Note F - Geographic and Other Information (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
		Years ended December 31,
		2013			2012
	Personal Care	$	11,459,482		$	9,438,345
	Medical		3,028,659			2,904,327
	Pharmaceutical		916,927			1,524,581
	Industrial and other		164,014			153,498
			15,569,082			14,020,751
	Less: Discounts and allowances		(152,189	)		(194,987	)
		$	15,416,893		$	13,825,764
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	'
		Years ended December 31,
		2013						2012
		Revenues			Long-Lived			Revenues		Long-Lived
					Assets					Assets
	United States	$	4,580,429		$	1,334,501		$	4,648,472	$	1,235,863
	Canada		3,390,619			-			2,860,154		-
	China		3,519,450			-			2,462,967		-
	France		856,285			-			903,137		-
	Other countries		3,070,110			-			2,951,034		-
		$	15,416,893		$	1,334,501		$	13,825,764	$	1,235,863
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]	'
		Years ended December 31,
		2013			2012
	Customer A	$	9,712,382		$	7,664,805
	Customer B		856,285			837,220
	All other customers		4,848,226			5,323,739
		$	15,416,893		$	13,825,764

Note_G_Comprehensive_Income_Ta

Note G - Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure Text Block [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	Changes in Accumulated Other	31-Dec-13			31-Dec-12
	Comprehensive Income
	Beginning balance - net of tax	$	178,979		$	34,612
	Unrealized (loss)/gain on marketable securities before reclassifications - net of tax		(65,531	)		167,298
	Realized gain/(loss) on sale of securities reclassified from accumulated other comprehensive income		18,675			(22,931	)
	Ending balance - net of tax	$	132,123		$	178,979

Note_I_Accrued_Expenses_Tables

Note I - Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2013
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		2013		2012
	Bonuses	$	250,000	$	229,000
	Distribution fees		196,558		196,617
	Payroll and related expenses		104,394		72,306
	Annual report expenses		66,000		66,000
	Audit fee		73,269		68,467
	Other		37,794		43,733
		$	728,015	$	676,123

Note_A_Nature_of_Business_and_1

Note A - Nature of Business and Summary of Significant Accounting Policies (Details) (USD $)	1 Months Ended	0 Months Ended	1 Months Ended		12 Months Ended
	Dec. 20, 2013	Jun. 14, 2013	Dec. 21, 2012	Jun. 18, 2012	Dec. 31, 2013	Dec. 31, 2012
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Number of Major Product Lines	'	'	'	'	2	'
Cash, FDIC Insured Amount (in Dollars)	'	'	'	'	$250,000	'
Common Stock, Dividends, Per Share, Cash Paid (in Dollars per share)	$0.50	$0.47	$0.44	$0.42	'	'
Payments of Ordinary Dividends, Common Stock (in Dollars)	'	'	'	'	4,458,544	6,251,158
Income Taxes Paid (in Dollars)	'	'	'	'	2,605,474	2,024,245
Number of Customers	'	'	'	'	2	2
Number of Vendors	'	'	'	'	5	'
Research and Development Expense (in Dollars)	'	'	'	'	717,000	693,000
Shipping, Handling and Transportation Costs (in Dollars)	'	'	'	'	45,000	65,000
Advertising Expense (in Dollars)	'	'	'	'	$16,000	$24,000
LUBRAJELB. And RENACIDIN IRRIGATIONB. [Member] | Product Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	94.40%	94.10%
LUBRAJEL [Member] | Product Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	91.40%	86.50%
RENACIDIN [Member] | Product Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	2.90%	7.60%
Special Dividend [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Common Stock, Dividends, Per Share, Cash Paid (in Dollars per share)	'	'	$0.50	'	'	'
Factory Equipment and Fixtures [Member] | Minimum [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'5 years	'
Factory Equipment and Fixtures [Member] | Maximum [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'7 years	'
Building [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'40 years	'
Building Improvements [Member] | Maximum [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'20 years	'
Waste Disposal System [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Property, Plant and Equipment, Useful Life	'	'	'	'	'7 years	'
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	69.00%	62.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	72.00%	52.00%
Supplier Concentration Risk [Member] | Cost of Goods, Product Line [Member]	'	'	'	'	'	'
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]	'	'	'	'	'	'
Concentration Risk, Percentage	'	'	'	'	67.00%	77.00%

Note_B_Marketable_Securities_D

Note B - Marketable Securities (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Investments, Debt and Equity Securities [Abstract]	'	'
Proceeds from Sale and Maturity of Marketable Securities	$4,139,018	$6,016,244
Marketable Securities, Realized Gain (Loss)	$18,675	($22,931)

Note_B_Marketable_Securities_D1

Note B - Marketable Securities (Details) - Available-For-Sale Securities (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Available for sale:	'	'
Cost	$8,660,997	$7,470,027
Fair Value	8,863,205	7,743,946
Unrealized Gain/(Loss)	202,208	273,919
Corporate Debt Securities [Member]	'	'
Available for sale:	'	'
Cost	203,920	203,920
Fair Value	200,053	203,357
Unrealized Gain/(Loss)	-3,867	-563
Fixed Income Mutual Funds [Member]	'	'
Available for sale:	'	'
Cost	7,325,930	6,991,181
Fair Value	7,425,687	7,242,998
Unrealized Gain/(Loss)	99,757	251,817
Equity And Other Mutual Funds [Member]	'	'
Available for sale:	'	'
Cost	1,131,147	274,926
Fair Value	1,237,465	297,591
Unrealized Gain/(Loss)	$106,318	$22,665

Note_C_Inventories_Details

Note C - Inventories (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]	'	'
Inventory Valuation Reserves	$20,000	$20,000

Note_C_Inventories_Details_Inv

Note C - Inventories (Details) - Inventories (USD $)	Dec. 31, 2013	Dec. 31, 2012
Inventories [Abstract]	'	'
Raw materials and work-in-process	$488,757	$481,544
Finished products	1,121,990	761,206
	$1,610,747	$1,242,750

Note_D_Income_Taxes_Details

Note D - Income Taxes (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Percentage of Net Income from Domestic Production Activities	9.00%	9.00%

Note_D_Income_Taxes_Details_Pr

Note D - Income Taxes (Details) - Provision for Income Taxes (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Provision for Income Taxes [Abstract]	'	'
Federal	$2,721,068	$2,015,345
State	19,646	21,011
	2,740,714	2,036,356
Deferred	'	'
Federal	-11,810	57,823
State	-351	1,718
	-12,161	59,541
Total provision for income taxes	$2,728,553	$2,095,897

Note_D_Income_Taxes_Details_Re

Note D - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of the Effective Income Tax Rate [Abstract]	'	'
Income taxes at statutory federal income tax rate of 34%	$2,935,000	$2,355,000
Income taxes at statutory federal income tax rate of 34%	34.00%	34.00%
State income taxes, net of Federal benefit	13,000	14,000
State income taxes, net of Federal benefit	0.20%	0.20%
Domestic Production Activities tax benefit	-180,000	-167,000
Domestic Production Activities tax benefit	-2.10%	-2.40%
Nondeductible expenses	1,000	1,000
Prior year over-accrual	-19,000	-24,000
Prior year over-accrual	-0.20%	-0.40%
R&D credits	-20,000	-83,000
R&D credits	-0.20%	-12.10%
Other, misc	-1,000	1,000
Tax exempt income	'	-1,000
Actual income tax expense	$2,729,000	$2,096,000
Actual income tax expense	31.70%	30.00%

Note_D_Income_Taxes_Details_De

Note D - Income Taxes (Details) - Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current	'	'
Accounts receivable	$6,089	$9,933
Inventories	16,862	14,348
Accrued expenses	206,500	192,307
	229,451	216,588
Non-current	'	'
Depreciation	-99,502	-98,800
Unrealized gain on marketable securities	-70,085	-94,940
	-169,587	-193,740
Net deferred tax asset	$59,864	$22,848

Note_E_Benefit_Plans_Details

Note E - Benefit Plans (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	4.00%	'
Defined Contribution Plan, Vesting Period	'1 year	'
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount	$17,500	$17,000
Fully Vested Term, Years	6	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	500,000	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	0	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	0	0
Matching Contributions [Member]	'	'
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	101,000	96,000
Additional Deferred Investment Employees Over 50 [Member]	'	'
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount	5,500	5,500
Discretionary Contributions [Member]	'	'
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Vesting Period	'2 years	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	$175,000	$175,000
Vesting at Two Years [Member]	'	'
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	20.00%	20.00%
Vesting Each Additional Year [Member]	'	'
Note E - Benefit Plans (Details) [Line Items]	'	'
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	20.00%	20.00%

Note_F_Geographic_and_Other_In2

Note F - Geographic and Other Information (Details)	12 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Number of Operating Segments	1

Note_F_Geographic_and_Other_In3

Note F - Geographic and Other Information (Details) - Net Sales (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]	'	'
Sales	$15,569,082	$14,020,751
Less: Discounts and allowances	-152,189	-194,987
	15,416,893	13,825,764
Personal Care [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales	11,459,482	9,438,345
Medical [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales	3,028,659	2,904,327
Pharmaceuticals [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales	916,927	1,524,581
Industrial and Other [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Sales	$164,014	$153,498

Note_F_Geographic_and_Other_In4

Note F - Geographic and Other Information (Details) - Geographic Information (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	$15,416,893	$13,825,764
Long-Lived Assets	1,334,501	1,235,863
UNITED STATES	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	4,580,429	4,648,472
Long-Lived Assets	1,334,501	1,235,863
CANADA	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	3,390,619	2,860,154
CHINA	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	3,519,450	2,462,967
FRANCE	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	856,285	903,137
Other Countries [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Revenues	$3,070,110	$2,951,034

Note_F_Geographic_and_Other_In5

Note F - Geographic and Other Information (Details) - Sales to Major Customers (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting, Other Significant Reconciling Item [Line Items]	'	'
Sales	$15,416,893	$13,825,764
Customer A [Member]	'	'
Segment Reporting, Other Significant Reconciling Item [Line Items]	'	'
Sales	9,712,382	7,664,805
Customer B [Member]	'	'
Segment Reporting, Other Significant Reconciling Item [Line Items]	'	'
Sales	856,285	837,220
All Other Customers [Member]	'	'
Segment Reporting, Other Significant Reconciling Item [Line Items]	'	'
Sales	$4,848,226	$5,323,739

Note_G_Comprehensive_Income_De

Note G - Comprehensive Income (Details) - Accumulated Other Comprehensive Income (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income [Abstract]	'	'
Beginning balance - net of tax	$178,979	$34,612
Unrealized (loss)/gain on marketable securities before reclassifications - net of tax	-65,531	167,298
Realized gain/(loss) on sale of securities reclassified from accumulated other comprehensive income	18,675	-22,931
Ending balance - net of tax	$132,123	$178,979

Note_H_Income_From_Damage_Sett1

Note H - Income From Damage Settlement (Details) (USD $)	12 Months Ended					12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jan. 31, 2013	Jan. 31, 2013	Jan. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	31-May-12
			Payments Per Month [Member]	Ramp Up Payment One [Member]	Ramp Up Payment Two [Member]	Damage Settlement [Member]	Damage Settlement [Member]	Damage Settlement [Member]
			Damage Settlement [Member]	Damage Settlement [Member]	Damage Settlement [Member]
Note H - Income From Damage Settlement (Details) [Line Items]	'	'	'	'	'	'	'	'
Other Receivables, Net, Current	$48,805	$518,050	$97,610	$48,805	$24,402	$48,805	$518,050	$518,050
Other Nonoperating Income	$1,070,561	$518,050	'	'	'	$1,070,561	$518,050	'

Note_I_Accrued_Expenses_Detail

Note I - Accrued Expenses (Details) - Accrued Expenses (USD $)	Dec. 31, 2013	Dec. 31, 2012
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]	'	'
Bonuses	$250,000	$229,000
Distribution fees	196,558	196,617
Payroll and related expenses	104,394	72,306
Other	37,794	43,733
	728,015	676,123
Accrued Annual Report [Member]	'	'
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]	'	'
Accrued professional fees	66,000	66,000
Accrued Audit Fee [Member]	'	'
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]	'	'
Accrued professional fees	$73,269	$68,467

Note_J_Related_Party_Transacti1

Note J - Related Party Transactions (Details) (USD $)	12 Months Ended		3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012
	Accounting and Tax Services [Member]	Accounting and Tax Services [Member]	President [Member]
Note J - Related Party Transactions (Details) [Line Items]	'	'	'
Related Party Transaction, Expenses from Transactions with Related Party	$14,000	$13,000	'
Related Party Transaction, Amounts of Transaction	'	'	$24,408